Biological Implants market research report analyzes the market for biological implant procedures. The total biological implants market is analyzed by tissue/muscle; origin, and mode of administration at global level and for each of the geographic regions - North America, Europe, Asia-Pacific and Rest of World. The biological implants market is segmented by Tissue/Muscle into Soft Tissue, Orthopedic, Cardiovascular and Other (includes Dental, Ophthalmic, and Urologic); by Origin into Allograft, and Xenograft; and by Mode of Administration into Injectable and Surgical. Business profiles of 25 major companies are discussed in the report. The research report serves as a guide to global biological implants industry covering 145 companies that are engaged in biological implants’ processing, R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this research report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the research report. Projections and estimates are graphically illustrated by geographic region with exclusive graphical representations provided for 241 exhibits.

Free Sample Research Report

Download Table of contents

Biological Implants are testimony to the huge advancements in medical science. The development of different types of implantable biomaterials according to the specified strength characteristics, conservation of significant biochemical properties, the lower immunogenity and higher inductivity of regenerative processes enables to carry out appropriate studies on the biochemical reactions following the implantation of biomaterials.

Global Biological Implants market is projected to reach about US$11.75 billion by 2012 at a growth rate compounded at 20.5% during the analysis period 2005-2012. This growth would be initiated especially by integration of Biological Implants into clinical trials. Biological Implants are expected to increase productivity by identifying potential biological substitutes for the body’s repairable parts. The United States is the leading market. Europe is the fastest growing market closely followed by Asia-Pacific. Europe and Asia-Pacific are expected to gain market shares while the US may lose market dominance.
Biological Implants find enormous application in the fields of neurological, cardiovascular, vascular, urogenital, nephrological and orthopedic systems. They are used to treat various disorders of the above systems. They also facilitate a distinctive system for development of skeletal specific drugs. Antibiotic-impregnated drips and spacers are used to heal acute cases of osteomyelitis and deep soft-tissue infections. This avoids the occurrence of systemic side effects. Major implant companies are also adding Biological Implants to their list of products. Though ethical issues pose a restriction to the advancement of Biological Implants, efforts are being made to replace artificial implants with Biological Implants to a certain extent.

Current investments in Biological Implants research and development efforts by researchers and companies would help in developing use of allografts and xenografts for tissue repair. The latest developments in tissue engineering and stem cell culturing would also contribute in a huge way to the development of Biological Implants. A huge market opportunity is expected for Biological Implants in the near future, as preference is given to biological and more natural materials than artificial materials.

-Aastrom Biosciences, Inc. (USA)
-Alphatec Spine, Inc. (USA)
-Arthro-Kinetics Plc (UK)
-Asterand Plc (UK)
-AutoTissue GmbH (Germany)
-bioMD Limited (Australia)
-BioTissue Technologies AG (Germany)
-CONMED Linvatec (USA)
-CryoLife, Inc. (USA)
-Curis, Inc. (USA)
-Exactech, Inc. (USA)
-Fascia Biosystems LLC (USA)
-Inamed Aesthetics (USA)
-Inion OY (Finland)
-IOP, Inc. (USA)
-IsoTis Inc. (USA)
-LifeCell Corporation (USA)
-Maxigen Biotech, Inc. (Taiwan)
-NuVasive Inc. (USA)
-Organogenesis, Inc. (USA)
-Osteotech, Inc. (USA)
-OsteoBiologics, Inc. (USA
-Pegasus Biologics, Inc. (USA)
-QLT, Inc. (Canada)
-Regeneration Technologies, Inc. (USA)
-Stryker Corporation (USA)
-Tutogen Medical, Inc. (USA)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	Provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the report summarizes the global market of Biological Implants by Tissue/Muscle, Origin and Mode of Administration. Global market is also analyzed by geographic regions including North America, Europe, Asia-Pacific and Rest of World. The chapter provides the market share values in percentage for each geographic region by country along with the market values. Global leading players are discussed.	$1250
III	Product / Technology Research	This chapter gives an insight into Biological Implants market including definitions, segmentation and applications. The chapter also provides market values in US$ (for the period 2005 through 2012) by Tissue/Muscle type, by Origin and by Mode of Administration. Global and regional markets are analyzed. The chapter also includes product trends, and potential opportunities.	$800
IV	Market Dynamics	Market Dynamics provides information on global markets for Biological Implants. The chapter includes global market analysis by geographic regions; analysis of each region by Tissue/Muscle type, Origin and Mode of Administration; a brief business profile of major global companies; and a glance at corporate activities such as mergers and acquisitions, partnerships, new product developments/launches etc. Also includes market trends and industry outlook.	$1950
V	Corporate Directory	This chapter provides the region-wise list of 164 companies, CROs, Cord blood banks and academic institutions that are engaged in Biological Implants products and services market.	$300